Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence is high among US adults, according to a study.

Both obesity and type 2 diabetes can override the potential protective effect of young age on liver health, leaving this ...

Saudi Arabia: A recent study, published in the Journal of Diabetes and its Complications has identified key predictors of ...

Britain's 'wine o'clock' culture may be partly to blame for an alarming trend that has seen deaths from chronic liver disease ...

Hepatic steatosis steadily increased in patients with HIV and HCV coinfection despite curative treatment with DAA therapy.

At 31 years old, I was told by doctors that if I didn’t stop drinking alcohol, I could die. I was shocked because I didn’t ...

How Timely Screening of liver function tests can prevent the development of underlying serious health diseases.

William Blair has the equivalent of a buy rating on the stock, as do all 13 analysts offering coverage of the stock on FactSet. The bank is one of many expecting Viking to be a takeover target, given ...

The GLP-1 receptor agonist improved both histology and fibrosis in patients, with additional improvements in their liver ...

Patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis who received a novel ...

On Tuesday, Viking Therapeutics, Inc. (NASDAQ:VKTX) highlighted the final results from its VOYAGE Phase 2b trial of VK2809 in ...